These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11759066)

  • 21. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
    Spearman P; Horton R; Ratner L; Kuli-Zade I
    J Virol; 1997 Sep; 71(9):6582-92. PubMed ID: 9261380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1.
    Brand D; Mallet F; Truong C; Roingeard P; Goudeau A; Barin F
    J Virol Methods; 1995 Feb; 51(2-3):153-68. PubMed ID: 7537750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells.
    Hong SS; Boulanger P
    J Virol; 1993 May; 67(5):2787-98. PubMed ID: 8474175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag-Pol.
    Chien AI; Liao WH; Yang DM; Wang CT
    Virology; 2006 Apr; 348(1):84-95. PubMed ID: 16442581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
    Derdowski A; Ding L; Spearman P
    J Virol; 2004 Feb; 78(3):1230-42. PubMed ID: 14722278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
    Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
    Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Nagashima K; Sowder RC; Poon DT; Gorelick RJ
    J Virol; 2003 May; 77(10):5547-56. PubMed ID: 12719547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
    Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
    Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
    Ono A; Freed EO
    J Virol; 2004 Feb; 78(3):1552-63. PubMed ID: 14722309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
    Ono A; Demirov D; Freed EO
    J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
    González SA; Affranchino JL
    Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells.
    Gay B; Tournier J; Chazal N; Carrière C; Boulanger P
    Virology; 1998 Aug; 247(2):160-9. PubMed ID: 9705909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.
    Platt EJ; Haffar OK
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4594-8. PubMed ID: 8183954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.
    Wang CT; Lai HY; Li JJ
    J Virol; 1998 Oct; 72(10):7950-9. PubMed ID: 9733833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assembly and release of human immunodeficiency virus type 1 Gag proteins containing tandem repeats of the matrix protein coding sequences in the matrix domain.
    Wang CT; Chen SS; Chiang CC
    Virology; 2000 Dec; 278(1):289-98. PubMed ID: 11112503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates.
    Spearman P; Ratner L
    J Virol; 1996 Nov; 70(11):8187-94. PubMed ID: 8892951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.